TrialActa diabetologica2022

Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial).

Rosaura Casas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.